<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mitani T</submitter><funding>NHGRI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>1981-2005</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8546040</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>108(10)</volume><pubmed_abstract>Neurodevelopmental disorders (NDDs) are clinically and genetically heterogenous; many such disorders are secondary to perturbation in brain development and/or function. The prevalence of NDDs is > 3%, resulting in significant sociocultural and economic challenges to society. With recent advances in family-based genomics, rare-variant analyses, and further exploration of the Clan Genomics hypothesis, there has been a logarithmic explosion in neurogenetic "disease-associated genes" molecular etiology and biology of NDDs; however, the majority of NDDs remain molecularly undiagnosed. We applied genome-wide screening technologies, including exome sequencing (ES) and whole-genome sequencing (WGS), to identify the molecular etiology of 234 newly enrolled subjects and 20 previously unsolved Turkis</pubmed_abstract><journal>American journal of human genetics</journal><pubmed_title>High prevalence of multilocus pathogenic variation in neurodevelopmental disorders in the Turkish population.</pubmed_title><pmcid>PMC8546040</pmcid><funding_grant_id>R01 GM132589</funding_grant_id><funding_grant_id>UM1 HG006542</funding_grant_id><funding_grant_id>U54 HG003273</funding_grant_id><funding_grant_id>R35 NS105078</funding_grant_id><funding_grant_id>U01 HG011758</funding_grant_id><funding_grant_id>K08 HG008986</funding_grant_id><funding_grant_id>T32 GM007526</funding_grant_id><pubmed_authors>Sezer O</pubmed_authors><pubmed_authors>Erdem HB</pubmed_authors><pubmed_authors>Yalcintepe S</pubmed_authors><pubmed_authors>Gibbs RA</pubmed_authors><pubmed_authors>Elcioglu N</pubmed_authors><pubmed_authors>Demiral E</pubmed_authors><pubmed_authors>Marafi D</pubmed_authors><pubmed_authors>Jolly A</pubmed_authors><pubmed_authors>Bozdogan S</pubmed_authors><pubmed_authors>Topcu V</pubmed_authors><pubmed_authors>Dawood M</pubmed_authors><pubmed_authors>Lupski JR</pubmed_authors><pubmed_authors>Punetha J</pubmed_authors><pubmed_authors>Yesilbas O</pubmed_authors><pubmed_authors>Grochowski CM</pubmed_authors><pubmed_authors>Bayram Y</pubmed_authors><pubmed_authors>Kilic B</pubmed_authors><pubmed_authors>Gulec EY</pubmed_authors><pubmed_authors>Ozalp O</pubmed_authors><pubmed_authors>Ayaz A</pubmed_authors><pubmed_authors>Pehlivan D</pubmed_authors><pubmed_authors>Fatih JM</pubmed_authors><pubmed_authors>Hu J</pubmed_authors><pubmed_authors>Isikay S</pubmed_authors><pubmed_authors>Yesil G</pubmed_authors><pubmed_authors>Aydin H</pubmed_authors><pubmed_authors>Du H</pubmed_authors><pubmed_authors>Akdemir ZC</pubmed_authors><pubmed_authors>Aslan H</pubmed_authors><pubmed_authors>Tos T</pubmed_authors><pubmed_authors>Jhangiani SN</pubmed_authors><pubmed_authors>Posey JE</pubmed_authors><pubmed_authors>Herman I</pubmed_authors><pubmed_authors>Carvalho CMB</pubmed_authors><pubmed_authors>Akay G</pubmed_authors><pubmed_authors>Gezdirici A</pubmed_authors><pubmed_authors>Candan S</pubmed_authors><pubmed_authors>Gungor S</pubmed_authors><pubmed_authors>Gul D</pubmed_authors><pubmed_authors>Doddapaneni H</pubmed_authors><pubmed_authors>Elmas M</pubmed_authors><pubmed_authors>Muzny DM</pubmed_authors><pubmed_authors>Baylor-Hopkins Center for Mendelian Genomics</pubmed_authors><pubmed_authors>Ceylan AC</pubmed_authors><pubmed_authors>Cicek S</pubmed_authors><pubmed_authors>Calame DG</pubmed_authors><pubmed_authors>Karaca E</pubmed_authors><pubmed_authors>Geckinli B</pubmed_authors><pubmed_authors>Duan R</pubmed_authors><pubmed_authors>Mitani T</pubmed_authors></additional><is_claimable>false</is_claimable><name>High prevalence of multilocus pathogenic variation in neurodevelopmental disorders in the Turkish population.</name><description>Neurodevelopmental disorders (NDDs) are clinically and genetically heterogenous; many such disorders are secondary to perturbation in brain development and/or function. The prevalence of NDDs is > 3%, resulting in significant sociocultural and economic challenges to society. With recent advances in family-based genomics, rare-variant analyses, and further exploration of the Clan Genomics hypothesis, there has been a logarithmic explosion in neurogenetic "disease-associated genes" molecular etiology and biology of NDDs; however, the majority of NDDs remain molecularly undiagnosed. We applied genome-wide screening technologies, including exome sequencing (ES) and whole-genome sequencing (WGS), to identify the molecular etiology of 234 newly enrolled subjects and 20 previously unsolved Turkis</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2026-05-31T06:04:02.21Z</modification><creation>2025-04-20T00:20:51.166Z</creation></dates><accession>S-EPMC8546040</accession><cross_references><pubmed>34582790</pubmed><doi>10.1016/j.ajhg.2021.08.009</doi></cross_references></HashMap>